Emit® 2000 Vancomycin Assay 10445338Recalls & reported problems
Siemens Healthcare Diagnostics Inc. · Emit® 2000 Vancomycin Assay labeled with the Beckman Coulter® name · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00842768023323), received between Jun 25, 2020 and Jun 25, 2020 — classified as 2 malfunctions.
The most frequently reported specific device problem is “High Test Results” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- High Test Results2
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 25, 2020High Test Results; High Test Results
AN ELEVATED EMIT 200 VANCOMYCIN RESULT, CONSIDERED BY THE PHYSICIAN TO BE DISCORDANT, WAS OBTAINED ON A PATIENT SAMPLE ON A BECKMAN AU5800 SYSTEM. THE RESULT WAS REPORTED TO THE PHYSICIAN(S) WHO QUESTIONED THE RESULT. THE SAME SAMPLE WAS REPROCESSED ON THE SAME SYSTEM AND ELEVATED RESULTS WERE OBTAINED AND REPORTED. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE VANCOMYCIN RESULTS WHICH WERE REGARDED AS DISCORDANT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10194316 ↗MalfunctionJun 25, 2020High Test Results; High Test Results
AN ELEVATED EMIT 200 VANCOMYCIN RESULT, CONSIDERED BY THE PHYSICIAN TO BE DISCORDANT, WAS OBTAINED ON A PATIENT SAMPLE ON A BECKMAN AU5800 SYSTEM. THE RESULT WAS REPORTED TO THE PHYSICIAN(S) WHO QUESTIONED THE RESULT. THE SAME SAMPLE WAS REPROCESSED ON THE SAME SYSTEM AND ELEVATED RESULTS WERE OBTAINED AND REPORTED. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE VANCOMYCIN RESULTS WHICH WERE REGARDED AS DISCORDANT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10194313 ↗
Other RADIOIMMUNOASSAY, VANCOMYCIN devices
- VITROS 6801709Ortho-Clinical Diagnostics, Inc. · RADIOIMMUNOASSAY, VANCOMYCIN1 recall23 reports
- Dimension Vista® Flex® reagent cartridge VANC 10445128Siemens Healthcare Diagnostics Inc. · RADIOIMMUNOASSAY, VANCOMYCIN13 reports
- ONLINE TDM Vancomycin Gen.3 08058849190Roche Diagnostics GmbH · RADIOIMMUNOASSAY, VANCOMYCIN6 reports
- ARCHITECT 6E44-21Abbott Laboratories · RADIOIMMUNOASSAY, VANCOMYCIN5 reports
- ONLINE TDM Vancomyin Gen.3 06779336190Roche Diagnostics GmbH · RADIOIMMUNOASSAY, VANCOMYCIN5 reports
- ONLINE TDM Vancomyin Gen.3 06779344190Roche Diagnostics GmbH · RADIOIMMUNOASSAY, VANCOMYCIN4 reports
- ONLINE TDM Vancomycin Gen.3 08445605190Roche Diagnostics GmbH · RADIOIMMUNOASSAY, VANCOMYCIN4 reports
- Dimension® Flex® reagent cartridge VANC 10444929Siemens Healthcare Diagnostics Inc. · RADIOIMMUNOASSAY, VANCOMYCIN2 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page